Pembrolizumab-associated acral necrosis and esophageal necrosis
Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of various advanced malignancies. By unleashing the immune system from its natural self-autoregulating mechanisms, malignant cells throughout the body are more effectively destroyed. These new immunotherapies have been used for a...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-12-01
|
Series: | Current Problems in Cancer: Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666621922000576 |